Papadopoulos et al., 1969 - Google Patents
Determination of human serum lipoprotein patterns by agarose gel electrophoresisPapadopoulos et al., 1969
- Document ID
- 12286850832431311969
- Author
- Papadopoulos N
- Kintzios J
- Publication year
- Publication venue
- Analytical Biochemistry
External Links
Snippet
An electrophoretic procedure is reported for the separation and detection of lipoproteins in serum. The technique utilizes agarose gel as supporting medium and oil red O dye for staining; it is rapid, very sensitive, relatively simple, and inexpensive. In normal nonfasting …
- 108090001030 Lipoproteins 0 title abstract description 34
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6827—Total protein determination, e.g. albumin in urine
- G01N33/6839—Total protein determination, e.g. albumin in urine involving dyes, e.g. Coomassie blue, bromcresol green
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/558—Immunoassay; Biospecific binding assay using diffusion or migration of antigen or antibody
- G01N33/561—Immunoelectrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44704—Details; Accessories
- G01N27/44717—Arrangements for investigating the separated zones, e.g. localising zones
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/04—Endocrine or metabolic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/90—Plate chromatography, e.g. thin layer or paper chromatography
- G01N30/94—Development
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Papadopoulos et al. | Determination of human serum lipoprotein patterns by agarose gel electrophoresis | |
Anderson et al. | Cholesterol in serum and lipoprotein fractions: its measurement and stability | |
Chin et al. | Separation and quantitative analysis of serum lipoproteins by means of electrophoresis on cellulose acetate | |
Warnick et al. | Gel isoelectric focusing method for specific diagnosis of familial hyperlipoproteinemia type 3. | |
CA1096757A (en) | Clinical procedure for measuring lipoprotein cholesterols | |
Bogoch et al. | Studies of hepatic function in diabetes mellitus, portal cirrhosis and other liver diseases: A correlation of clinical, biochemical and liver needle biopsy findings I. Diabetes mellitus | |
Dyerberg et al. | Quantitative plasma lipoprotein estimation by agarose gel electrophoresis | |
JP2002139501A (en) | Method for analyzing and diagnosing lipoprotein subclass | |
Robinson et al. | Quantitative thin layer chromatography of serum phospholipids | |
WO2015079000A1 (en) | Method for the characterization of lipoproteins | |
Holmes et al. | Hyperlipidemia as a biochemical basis of magnetic resonance plasma test for cancer | |
Kawakami et al. | A rapid electrophoretic method for the detection of serum Lp (a) lipoprotein | |
RU2275648C2 (en) | Method of electron-paramagnetic resonance stereoscopic determination of changes in transportation properties of albumin in albumin-containing sample, electron-paramagnetic resonance-spectrometer for realization of the method and application of the method for diagnosing and inspecting albumin-containing preparations | |
Wissler et al. | Quantitating rhesus monkey atherosclerosis progression and regression with time | |
EP1045247B1 (en) | A method for separating and assaying lipoprotein, an assembly for performing such a method, and a system including such an assembly | |
US20240168029A1 (en) | Application of composition in preparation of drug for diagnosing infantile hemangioma and/or monitoring progress and prognosis thereof, and kit and drug | |
Simpson et al. | High-density lipoprotein subfractions as measured by differential polyanionic precipitation and rate zonal ultracentrifugation. | |
Heuck et al. | Microdetermination of cholesterol in serum lipoproteins | |
Warnick | Laboratory measurement of lipid and lipoprotein risk factors | |
ROBOZ et al. | Serum lipid studies in multiple sclerosis | |
Papadopoulos | Abrnomal lipoprotein patterns in human serum as determined by agarose gel electrophoresis. | |
Sirtori et al. | Phenotyping of type II and IV hyperlipoproteinemias by a simple, quantitative agarose gel lipoprotein electrophoresis | |
Stoltz et al. | Plasma viscosity and biochemical parameters in the “fatty” rat | |
Chihara et al. | Medical and Biochemical Application of Infrared Absorption Spectra. III. Studies on Biological Lipids by Infrared Spectra.(1). Infrared Spectra of Total Lipids in Diabetes Serum | |
千原呉郎 et al. | Medical and Biochemical Application of Infrared Absorption Spectra. III. Studies on Biological Lipids by Infrared Spectra.(1). Infrared Spectra of Total Lipids in Diabetes Serum |